Evidence map›Paper›PMID 25533346›Full record

ArticleCell reports2014

p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche.

Kyung Hee Chang, Amitava Sengupta, Ramesh C Nayak, Angeles Duran, Sang Jun Lee, Ronald G Pratt, Ashley M Wellendorf, Sarah E Hill, Marcus Watkins, Daniel Gonzalez-Nieto and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Review
  3. Hematopoietic Stem Cells and Their Niche in Bone Marrow.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Autophagic Mediators in Bone Marrow Niche Homeostasis.Advances in experimental medicine and biology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Kyung Hee ChangDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; Hoxworth Blood Center, University of Cincinnati College of Medicine, 3130 Highland Avenue, Cincinnati, OH 45267, USA.
Amitava SenguptaDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; Stem Cell and Leukemia Lab, Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4, Raja SC Mullick Road, Kolkata 700032, West Bengal, India.
Ramesh C NayakDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Angeles DuranSanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Sang Jun LeeSanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Ronald G PrattImaging Research Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Ashley M WellendorfDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Sarah E HillHoxworth Blood Center, University of Cincinnati College of Medicine, 3130 Highland Avenue, Cincinnati, OH 45267, USA.
Marcus WatkinsDivision of Bone and Mineral Diseases, Departments of Internal Medicine and Cell Biology and Physiology, Washington University School of Medicine, One Brookings Drive, St. Louis, MO 63110, USA.
Daniel Gonzalez-NietoDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; Bioengineering and Telemedicine Group, Center for Biomedical Technology, Universidad-Politécnica de Madrid, Pozuelo de Alarcon 28223, Spain.
Bruce J AronowBiomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Daniel T StarczynowskiDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Roberto CivitelliDivision of Bone and Mineral Diseases, Departments of Internal Medicine and Cell Biology and Physiology, Washington University School of Medicine, One Brookings Drive, St. Louis, MO 63110, USA.
Maria T Diaz-MecoSanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Jorge MoscatSanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Jose A CancelasDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; Hoxworth Blood Center, University of Cincinnati College of Medicine, 3130 Highland Avenue, Cincinnati, OH 45267, USA. Electronic address: jose.cancelas@uc.edu.
Cincinnati Children's Hospital Medical Center · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Cincinnati Medical Center · USWashington University in St. Louis · USUniversidad Politécnica de Madrid · ES

Funding

Training Program in Cancer TherapeuticsT32CA117846 · NCI · UNIVERSITY OF CINCINNATI · PI PRICE, CAROLYN M, TAKIAR, VINITA · 2006 to 2022
$6.5M
INTERCELLULAR COMMUNICATION IN BONE CELL PHYSIOLOGYR01AR041255 · NIAMS · WASHINGTON UNIVERSITY · PI CIVITELLI, ROBERTO · 1997 to 2017
$5.3M
Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lungR01CA132847 · NCI · UNIVERSITY OF CINCINNATI · PI MOSCAT, JORGE · 2009 to 2013
$2.0M
The Par-4/PKCz complex in prostate cancerR01CA134530 · NCI · UNIVERSITY OF CINCINNATI · PI DIAZ MECO CONDE, MARIA TERESA · 2009 to 2013
$1.8M
Rac GTPase Inhibition in Chronic Myelogenous LeukemiaR01HL087159 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CANCELAS, JOSE A. · 2009 to 2012
$1.7M
Cadherin Mediated Cell-Cell Interactions in the Bone MicroenvironmentR01AR055913 · NIAMS · WASHINGTON UNIVERSITY · PI CIVITELLI, ROBERTO · 2009 to 2013
$1.6M
Smad4/B-Catenin Signaling Cross-Talk for OsteoblastogenesisR01AR056678 · NIAMS · WASHINGTON UNIVERSITY · PI CIVITELLI, ROBERTO · 2010 to 2014
$1.6M
NCI NIH HHS R01 CA132847NCI NIH HHS R01 CA134530NCI NIH HHS R01-CA134530NCI NIH HHS R01-CA170225NCI NIH HHS T32 CA117846NHLBI NIH HHS HL087159S1NHLBI NIH HHS R01 HL087159NHLBI NIH HHS R01-HL087159NIAMS NIH HHS R01 AR041255NIAMS NIH HHS R01-AR041255NIAMS NIH HHS R01 AR055913NIAMS NIH HHS R01-AR055913NIAMS NIH HHS R01 AR056678NIAMS NIH HHS R01-AR056678NIDDK NIH HHS P30 DK090971
6 · The paper itself

Abstract

In the bone marrow (BM), hematopoietic progenitors (HPs) reside in specific anatomical niches near osteoblasts (Obs), macrophages (MΦs), and other cells forming the BM microenvironment. A connection between immunosurveillance and traffic of HP has been demonstrated, but the regulatory signals that instruct the immune regulation of HP circulation are unknown. We discovered that the BM microenvironment deficiency of p62, an autophagy regulator and signal organizer, results in loss of autophagic repression of macrophage contact-dependent activation of Ob NF-κB signaling. Consequently, Ob p62-deficient mice lose bone, Ob Ccl4 expression, and HP chemotaxis toward Cxcl12, resulting in egress of short-term hematopoietic stem cells and myeloid progenitors. Finally, Ccl4 expression and myeloid progenitor egress are reversed by deficiency of the p62 PB1-binding partner Nbr1. A functional "MΦ-Ob niche" is required for myeloid progenitor/short-term stem cell retention, in which Ob p62 is required to maintain NF-κB signaling repression, osteogenesis, and BM progenitor retention.

Indexed as

OsteogenesisSignal TransductionStem Cell NicheAdaptor Proteins, Signal TransducingAnimalsAutophagyChemokine CCL4Heat-Shock ProteinsHematopoietic Stem CellsI-kappa B KinaseIntracellular Signaling Peptides and ProteinsMacrophagesMiceNF-kappa BOsteoblastsProteinsAdaptor Proteins, Signal TransducingChemokine CCL4Heat-Shock ProteinsI-kappa B KinaseIntracellular Signaling Peptides and ProteinsNbr1 protein, mouseNF-kappa BProteinsSequestosome-1 ProteinSqstm1 protein, mouse

Identifiers

PMID25533346
PMCPMC4277497
OpenAlexW1972598446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.